While OPN levels are significantly higher in CSF of MS patients compared to non-inflammatory controls, we did not detect any significant difference between MS patients and patients with other inflammatory neurological disorders regarding their CSF concentration of OPN. The gene discussed is SPP1; the disease is myeloid sarcoma.